PIN7 ECONOMIC EVALUATION OF ELVITEGRAVIR/COBICISTAT/EMTRICITABINE/TENOFOVIR ALAFENAMIDE (GENVOYA®) AS A COMPLETE TREATMENT REGIMEN FOR HIV-1 INFECTION IN ADULTS WHO ARE ANTIRETROVIRAL THERAPY-NAÏVE IN MEXICO
Abstract
Authors
B.A. Godina-Ortiz J.Á. Paladio Hernández M. Leal-González E.A. Devars-Cleren P. Vera-Rendón L.T. Barrera-Balderas